Over the last 52-week period, shares of Johnson & Johnson are up 15.56%. Analysts have adjusted their estimates lower for EPS and revenues over the past 90 days. Analysts seem to have settled on a Neutral rating with Johnson & Johnson. The strength of this rating has maintained conviction over the past three months.